The global pneumococcal vaccine market is expected to grow at a CAGR of 6.17% to reach a total market size of US$10.436 billion by 2023, increasing from US$7.287 billion in 2017. Rising incidence of pneumococcal diseases like pneumonia, meningitis, febrile bacteraemia, otitis media, sinusitis, bronchitis and others is driving the demand for pneumococcal vaccines. According to WHO, pneumococcal vaccine had been introduced in 134 countries by 2016 end and estimated global coverage was about 42%. G Read more...
The global Human Papilloma Virus (HPV) Vaccine market is expected to grow at a CAGR of 9.79% during the forecast period to reach a total market size of US$5.790 billion by 2024, increasing from US$3.305 billion in 2018.According to the WHO guidelines, routine vaccination is recommended to all countries along with other vaccinations. Human Papilloma Virus (HPV) Vaccine protects from certain types of Human Papilloma Viruses that can lead to cancer or genital warts. According to the WHO guideline Read more...
The global pet vaccine market is projected to witness a CAGR of 7.10% during the forecast period to reach a total market size of US$4.402 billion by 2023, increasing from US$3.124 billion in 2018. Regular Vaccination is an important part of a responsible pet ownership. Maintaining the pet’s immunity to diseases plays an important part in community health in general. The growing adoption rate of pets and growing community awareness regarding pet health has been significantly driving the demand Read more...
The global influenza vaccine market is projected to grow at a CAGR of 6.37% to reach US$7.547 billion by 2024, from US$5.209 billion in 2018. Due to the constant changing of circulating influenza viruses, influenza vaccines strains are changed annually (for both the Northern Hemisphere and the Southern Hemisphere) to more closely match currently circulating virus strains (source: WHO). Hence the rising R&D expenditure and advancements in vaccine technology are driving the growth of the globa Read more...
The precision medicine market is projected to grow at a CAGR of 8.47% to reach US$87.877 billion in 2023 from US$53.966 billion in 2017. Major factors responsible for the global precision medicine market growth during the next five years are mainly, increasing efforts to characterize genes and rise in demand for personalized treatment. The global precision medicine sales are expected to be further boosted by rapid technological advancements, favorable government initiatives, and advancements in Read more...
Europe over-the-counter (OTC) drugs market is projected to witness a compound annual growth rate of 6.92% during the forecast period, reaching a total market size of US$39.560 billion in 2023 from US$26.486 billion in 2017. Rising pharmaceutical (OTC drug) spending in European countries as an affordable treatment option is escalating the demand for OTC drugs in the region. This is supported by rising healthcare expenditure in European countries such as Germany and France where high awareness abo Read more...
The Asia Pacific Over-the- Counter Drugs Market was valued at US$X.XX billion in 2016 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2022. This research study examines the Over-the- Counter Drugs market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in additio Read more...
The Middle East and Africa Over-the- Counter Drugs Market was valued at US$X.XX billion in 2016 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2022. This research study examines the Over-the- Counter Drugs market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, Read more...
The North America over-the-counter market was valued at US$43.341 billion in 2017 and is projected to expand at a CAGR of 4.24% over the forecast period to reach US$55.618 billion by 2023. Over the counter drugs are those drugs that are available to the consumers without the prescription. The high frequency of occurrences for many of the symptoms for which the over the counter medicines are required is driving the growth of the market. Moreover, the ability to provide convenience value alo Read more...
The South American Over-the- Counter Drugs Market was valued at US$X.XX billion in 2016 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2022. This research study examines the Over-the- Counter Drugs market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addit Read more...
.jpg)
